leflunomide has been researched along with Dengue in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Dengue: An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wu, WL | 1 |
Ho, LJ | 1 |
Chen, PC | 1 |
Tsai, YT | 1 |
Hsu, ST | 1 |
Chang, DM | 1 |
Lai, JH | 1 |
1 other study available for leflunomide and Dengue
Article | Year |
---|---|
Immunosuppressive effects and mechanisms of leflunomide in dengue virus infection of human dendritic cells.
Topics: Cell Differentiation; Cell Movement; Cells, Cultured; Chemokine CCL19; Chemokine CCL21; Dendritic Ce | 2011 |